skip to navigation

Paul Finger

Paul Finger MD, FACS

Other (e.g., Education, Research)
Job Title:
Medical School:
Tulane Medical School
Residency Program:
Manhattan Eye, Ear and Throat Hospital
New York, United States
The Eye Cancer Foundation, Executive Director
Contact Information:
115 East 61st Street - 5B
New York, NY
United States 10065
Phone: 212-832-8170
Fax: 212-888-4030
Web site:

Internationally Recognized Leading Eye Cancer Specialist, Paul T. Finger, MD, FACS is a Clinical Professor of Ophthalmology at the New York University School of Medicine and Director of Ocular Oncology at The New York Eye Cancer Center, The New York Eye and Ear Infirmary (NYEE), Manhattan Eye Ear and Throat Hospital (MEETH), New York University School of Medicine and Beth Israel Comprehensive Cancer Center.
Dr. Paul T. Finger, M.D., F.A.C.S. is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology. He is the founding Director of Ocular Tumor Services at several renowned institutions, including the New York University School of Medicine (where he also serves as a clinical professor of Ophthalmology), New York Eye and Ear Infirmary, Tisch Hospital, and Manhattan Eye, Ear and Throat Hospital. He is fellowship trained in ocular tumor, orbital disease and ophthalmic radiation therapy.

Dr. Finger has extensive experience in the diagnosis and treatment of cancers in and around the eye. These cancers are all rare and typically diagnosed without biopsy. That is why his more than 25 years of experience with research, teaching and clinical care are so important. Dr. Finger uses the latest diagnostic imaging and ultrasound techniques. In fact, he has researched and developed many of the diagnostic techniques now employed around the world. These include high frequency anterior segment ultrasound ("ultrasonic biomicroscopy," or UBM), OCT (Optical Coherence Tomography), digital imaging and the "Finger Iridectomy Technique" biopsy when indicated.

The most primary intraocular cancer is melanoma. It is often called choroidal melanoma. Dr. Finger offers the most sophisticated diagnostic and therapeutic options for these cancers, including brachytherapy (radioactive material sealed in needles, seeds, or catheters is placed directly into or near a tumor). Dr. Finger has pioneered the use of palladium-103 seeds in ophthalmic plaque, which he has found to offer comparatively better eye and vision sparing than that reported for iodine-125 or ruthenium-106 (in most cases).

Dr. Finger believes in excellence through innovation. Never satisfied with less effective treatments, he invented slotted eye plaques for those rare cases where a choroidal melanoma is wrapped around the optic nerve, aspiration-cutter assisted anterior segment tumor biopsy to increase safety and effectiveness and numerous other techniques described on this website.

Dr. Finger has published more than 200 original articles, 30 book chapters and scientific reviews. He has worked on national and international committees to improve radiation therapy and develop a standard "universal" language to classify eye tumors. As Chair of the Ophthalmic Oncology Task Force of the American Joint Committee on Cancer, he worked with 45 eye cancer specialists from 11 countries to make universal staging and a common scientific language a reality.

Stay connected:         Follow us on Instagram

Web site design and web development by D3 Solutions